Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 12/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.42 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.42 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.42 |
| ▸ | DNPH1 | O43598 | 2/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.41 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18937379 | 0.88 | P2RY12 (0.42) | P2RY12ADORA1PRMT6P2RY2P2RY1 | |
| SCHEMBL26109732 | 0.86 | PRMT6 (0.45) | P2RY12ADORA1PRMT6P2RY2P2RY1 | |
| SCHEMBL31430113 | 0.86 | P2RY12 (0.41) | P2RY12PRMT6P2RY2P2RY1P2RY6 | |
| SCHEMBL26112399 | 0.85 | PRMT6 (0.48) | P2RY12ADORA1PRMT6P2RY2P2RY1 | |
| SCHEMBL31670488 | 0.84 | PRMT6 (0.42) | P2RY12ADORA1PRMT6 | |
| SCHEMBL19250015 | 0.84 | P2RY12 (0.41) | P2RY12ADORA1PRMT6P2RY2P2RY1 | |
| SCHEMBL13020575 | 0.84 | MEN1 (0.50) | P2RY12ADORA1PRMT6 | |
| SCHEMBL13020577 | 0.84 | PRMT6 (0.49) | P2RY12ADORA1PRMT6P2RY2P2RY1 | |
| SCHEMBL18927159 | 0.83 | P2RY12 (0.45) | P2RY12ADORA1PRMT6P2RY2P2RY1 | |
| SCHEMBL22220010 | 0.83 | P2RY12 (0.42) | P2RY12ADORA1PRMT6P2RY2P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127277-B2 | Methods and compositions for prevention or treatment of RSV infection | ALNYLAM PHARMACEUTICALS, INC. (US) | 2015-09-08 | — | — | US | disclosed |